zofenopril has been researched along with Injury, Myocardial Reperfusion in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, MJ; Bradley, JM; Cirino, G; Donnarumma, E; Evangelista, S; Goodchild, TT; Islam, KN; Jenkins, JS; Lefer, DJ; Organ, CL; Patel, RA; Polhemus, DJ; Rushing, AM; Scarborough, AL | 1 |
| Frascarelli, S; Ghelardoni, S; Ronca-Testoni, S; Zucchi, R | 1 |
| Boraso, A; Cargnoni, A; Ceconi, C; Curello, S; Ferrari, R; Visioli, O | 1 |
| Cordis, GA; Das, DK; Engelman, RM; Liu, X; Rousou, JA | 1 |
| Kloner, RA; Przyklenk, K | 1 |
| Bel, KJ; de Graeff, PA; de Langen, CD; Mook, PH; Tio, RA; van Gilst, WH; van Wijngaarden, J; Wesseling, H; Wolters, KG | 1 |
| Chopra, M; Dargie, HJ; McMurray, J; Smith, WE; Stewart, J | 1 |
7 other study(ies) available for zofenopril and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Topics: Animals; Antihypertensive Agents; Biological Availability; Blotting, Western; Captopril; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Heart; Hydrogen Sulfide; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Ramipril; Random Allocation; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; Sulfurtransferases; Swine; Swine, Miniature; Troponin I | 2016 |
Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Rate; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar | 2004 |
Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Captopril; Creatine Kinase; Hemodynamics; In Vitro Techniques; Lactates; Male; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Oxidation-Reduction; Phosphocreatine; Rabbits | 1992 |
Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Circulation; Creatine Kinase; Fosinopril; Free Radical Scavengers; In Vitro Techniques; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Reperfusion Injury; Myocardium; Phospholipids; Proline; Rats; Rats, Inbred Strains; Ventricular Function, Left | 1992 |
Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Coronary Circulation; Dogs; Enalaprilat; Indomethacin; Myocardial Contraction; Myocardial Reperfusion Injury; Prostaglandins; Sulfhydryl Compounds | 1991 |
The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Creatine Kinase; Electric Stimulation; Heart; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Purines; Renin; Swine; Tachycardia; Time Factors; Ventricular Function | 1990 |
Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Evaluation, Preclinical; Free Radical Scavengers; Humans; In Vitro Techniques; Myocardial Reperfusion Injury | 1990 |